Literature DB >> 9283586

DNA hypomethylation in breast cancer: an independent parameter of tumor progression?

J Bernardino1, C Roux, A Almeida, N Vogt, A Gibaud, M Gerbault-Seureau, H Magdelenat, C A Bourgeois, B Malfoy, B Dutrillaux.   

Abstract

The global DNA methylation status was investigated on a series of 59 breast cancers by Southern blotting, using methylation sensitive restriction enzymes. By comparison to control DNA, almost all tumor DNAs were found globally hypomethylated. However, the demethylation was variable from tumor to tumor. Compared to other biological parameters, the methylation did not correlate with chromosome alterations, steroid hormone receptor status, or histopathological grading. Tumors which appeared to be the most evolved for other parameters were only mildly hypomethylated, whereas tumors with strongly hypomethylated DNA corresponded to those with slight alterations of the other parameters. Thus, DNA hypomethylation is a consistent characteristic of breast cancer, but its variations may not correlate with tumor progression of most breast cancers.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9283586     DOI: 10.1016/s0165-4608(96)00385-8

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  23 in total

1.  Associations between genetic variation in one-carbon metabolism and LINE-1 DNA methylation in histologically normal breast tissues.

Authors:  Adana A M Llanos; Catalin Marian; Theodore M Brasky; Ramona G Dumitrescu; Zhenhua Liu; Joel B Mason; Kepher H Makambi; Scott L Spear; Bhaskar V S Kallakury; Jo L Freudenheim; Peter G Shields
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

2.  Expression of MAGE-A1 mRNA is associated with gene hypomethylation in hepatocarcinoma cell lines.

Authors:  Jiang Xiao; Hong-Song Chen; Ran Fei; Xu Cong; Li-ping Wang; Yan Wang; Dong Jiang; Lai Wei; Yu Wang
Journal:  J Gastroenterol       Date:  2005-07       Impact factor: 7.527

3.  A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.

Authors:  Qing Xu; Yue Jiang; Yu Yin; Qi Li; Jun He; Yi Jing; Yan-Ting Qi; Qian Xu; Wei Li; Bo Lu; Stephen S Peiper; Bing-Hua Jiang; Ling-Zhi Liu
Journal:  J Mol Cell Biol       Date:  2012-08-29       Impact factor: 6.216

4.  High-throughput and cost-effective global DNA methylation assay by liquid chromatography-mass spectrometry.

Authors:  Xingnan Li; Adrian A Franke
Journal:  Anal Chim Acta       Date:  2011-07-19       Impact factor: 6.558

Review 5.  Epigenetic changes in BRCA1-mutated familial breast cancer.

Authors:  Bradley Downs; San Ming Wang
Journal:  Cancer Genet       Date:  2015-02-13

6.  Overexpression and hypomethylation of flap endonuclease 1 gene in breast and other cancers.

Authors:  Purnima Singh; Ming Yang; Huifang Dai; Dianke Yu; Qin Huang; Wen Tan; Kemp H Kernstine; Dongxin Lin; Binghui Shen
Journal:  Mol Cancer Res       Date:  2008-11       Impact factor: 5.852

7.  Real-time methylomic aberrations during initiation and progression of induced human mammary epithelial cell tumorigenesis.

Authors:  Natalie E Mitchell; MacKenzie L Wilson; Molly S Bray; David K Crossman; Trygve O Tollefsbol
Journal:  Epigenomics       Date:  2013-04       Impact factor: 4.778

8.  Correlation of DNA hypomethylation at pericentromeric heterochromatin regions of chromosomes 16 and 1 with histological features and chromosomal abnormalities of human breast carcinomas.

Authors:  Hitoshi Tsuda; Teruko Takarabe; Yae Kanai; Takashi Fukutomi; Setsuo Hirohashi
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

9.  Association between global DNA hypomethylation in leukocytes and risk of breast cancer.

Authors:  Ji-Yeob Choi; Smitha R James; Petra A Link; Susan E McCann; Chi-Chen Hong; Warren Davis; Mary K Nesline; Christine B Ambrosone; Adam R Karpf
Journal:  Carcinogenesis       Date:  2009-07-07       Impact factor: 4.944

Review 10.  Breast cancer epigenetics: from DNA methylation to microRNAs.

Authors:  Jürgen Veeck; Manel Esteller
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-01-27       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.